PL2062569T3 - Dopochwowy układ dostarczania leku - Google Patents

Dopochwowy układ dostarczania leku

Info

Publication number: PL2062569T3
Authority: PL; Poland
Prior art keywords: delivery system; core; compartment; drospirenone; vaginal delivery
Prior art date: 2007-11-22

Application number

PL07397043T

Other languages

English (en)

Inventor

Christine Talling

Antti Keinänen

Svante Holmberg

Hannu Nikander

Original Assignee

Bayer Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-22

Filing date

2007-11-22

Publication date

2011-10-31

2007-11-22 Application filed by Bayer Oy filed Critical Bayer Oy

2011-10-31 Publication of PL2062569T3 publication Critical patent/PL2062569T3/pl

Links

208000034423 Delivery Diseases 0.000 title 1
230000009677 vaginal delivery Effects 0.000 title 1
METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 2
METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 2
229960004845 drospirenone Drugs 0.000 abstract 2
239000012528 membrane Substances 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
229940011871 estrogen Drugs 0.000 abstract 1
239000000262 estrogen Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Medicinal Preparation (AREA)

PL07397043T 2007-11-22 2007-11-22 Dopochwowy układ dostarczania leku PL2062569T3 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP07397043A EP2062569B1 (en)	2007-11-22	2007-11-22	Vaginal delivery system

Publications (1)

Publication Number	Publication Date
PL2062569T3 true PL2062569T3 (pl)	2011-10-31

Family

ID=39273813

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07397043T PL2062569T3 (pl)	2007-11-22	2007-11-22	Dopochwowy układ dostarczania leku

Country Status (6)

Country	Link
EP (1)	EP2062569B1 (pl)
AT (1)	ATE508734T1 (pl)
DK (1)	DK2062569T3 (pl)
ES (1)	ES2365552T3 (pl)
PL (1)	PL2062569T3 (pl)
PT (1)	PT2062569E (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20095563A7 (fi) *	2009-05-20	2010-11-21	Bayer Schering Pharma Oy	Vaginaalinen antojärjestelmä
JP2019504021A (ja) *	2015-12-21	2019-02-14	バイエル・オーイュー	膣リングを製造する方法
CN110585246B (zh) *	2019-09-22	2020-06-02	深圳市多微生保健食品有限公司	一种阴道抑菌制剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4469671A (en) *	1983-02-22	1984-09-04	Eli Lilly And Company	Contraceptive device
WO1997002015A1 (en) *	1995-07-04	1997-01-23	Akzo Nobel N.V.	Ring-shaped devices
US5972372A (en) *	1996-07-31	1999-10-26	The Population Council, Inc.	Intravaginal rings with insertable drug-containing core
US6063395A (en) *	1998-11-12	2000-05-16	Leiras Oy	Drug delivery device especially for the delivery of progestins and estrogens
AU2002313517B2 (en) *	2001-08-31	2007-09-06	Bayer Schering Pharma Oy	Drug delivery system
DE602004026173D1 (de) *	2003-04-29	2010-05-06	Gen Hospital Corp	Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
WO2005089723A1 (en) *	2004-03-24	2005-09-29	N.V. Organon	Drug delivery system based on polyethylene vinylacetate copolymers
EP1853272A1 (en) *	2005-02-03	2007-11-14	Duramed Pharmaceuticals, Inc.	Compositions of unconjugated estrogens and methods for their use

2007
- 2007-11-22 PL PL07397043T patent/PL2062569T3/pl unknown
- 2007-11-22 PT PT07397043T patent/PT2062569E/pt unknown
- 2007-11-22 AT AT07397043T patent/ATE508734T1/de active
- 2007-11-22 EP EP07397043A patent/EP2062569B1/en not_active Not-in-force
- 2007-11-22 ES ES07397043T patent/ES2365552T3/es active Active
- 2007-11-22 DK DK07397043.6T patent/DK2062569T3/da active

Also Published As

Publication number	Publication date
EP2062569A1 (en)	2009-05-27
PT2062569E (pt)	2011-07-25
ES2365552T3 (es)	2011-10-06
DK2062569T3 (da)	2011-08-29
ATE508734T1 (de)	2011-05-15
EP2062569B1 (en)	2011-05-11

Similar Documents

Publication	Publication Date	Title
MX2010003656A (es)	2010-04-21	Sistema de administracion vaginal.
WO2006084164A8 (en)	2007-10-18	Gastric retention and controlled release delivery system
WO2006127618A3 (en)	2007-02-22	Compressible gum based delivery systems for the release of ingredients
ZA200701263B (en)	2009-03-25	Controlled release delivery system for bioo-active agents
AR048185A1 (es)	2006-04-05	Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico
WO2007117465A3 (en)	2008-08-28	Indazole compounds
EP1357870A4 (en)	2005-12-14	BIOADHESIVE FOAM FILTER WITH FIXED RELEASE
WO2006010097A3 (en)	2006-08-10	Sustained release compositions containing progesterone receptor modulators
MXPA05009910A (es)	2005-11-04	Sistema de liberacion controlada que contiene acetato isobutirato de sacarosa.
PT1827396T (pt)	2016-08-31	Medicamento oral de libertação modificada de pelo menos um princípio ativo sob forma multimicrocapsular
PL2131847T3 (pl)	2011-05-31	Lek zawierający przynajmniej jeden gestagen
WO2008123582A1 (ja)	2008-10-16	テトラヒドロイソキノリン化合物
IL184448A (en)	2014-12-31	Phosphate-binding compounds with pharmaceutical activity, their manufacture, their containing compounds and their uses
PT2062569E (pt)	2011-07-25	Sistema de administração vaginal
EP2037663A4 (en)	2015-12-30	PROCESS, SYSTEM AND DEVICE FOR SAVING AND PLAYING POC MEETINGS
WO2009086202A3 (en)	2009-09-17	Methods for treating neuropsychiatric conditions
WO2008089488A3 (en)	2008-10-23	Biodegradable intravaginal devices for delivery of therapeutics
WO2007138112A3 (en)	2008-05-15	Compounds that interact with ion channels, in particular with ion channels from the kv family
AR076588A1 (es)	2011-06-22	Sistema de liberacion vaginal
IL179846A (en)	2012-07-31	A system for administering drugs that include a core and a membrane that contains a regulating factor and a method for its use
CA2526954A1 (en)	2006-06-15	Antibiotics containing bone substitute material with sustained active substance release
EP1637167A3 (en)	2006-04-05	New injectable formulations containing progesterone
MX2009005446A (es)	2009-06-02	Sistema de suministro vaginal para mirtazapina.
FR2894143B1 (fr)	2008-05-02	Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
PT2190431E (pt)	2013-10-09	Composições compreendendo um agonista do recetor dos glucocorticoides dissociados para tratamento ou controlo de inflamação do segmento anterior